MedDataX Logo

UVA1 Phototherapy in Acral Vitiligo

NCT ID: NCT03378011

Last Updated: 2017-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

evaluate the effect of UVA1 phototherapy in the treatment of acral vitiligo.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acral Vitiligo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

UVA1 phototherapy

UVA1 phototherapy in acral vitiligo

Group Type ACTIVE_COMPARATOR

phototherapy

Intervention Type OTHER

phototherapy either UVA1 or topical PUVA on acral vitiligo

Topical PUVA

Topical PUVA in acral vitiligo

Group Type ACTIVE_COMPARATOR

phototherapy

Intervention Type OTHER

phototherapy either UVA1 or topical PUVA on acral vitiligo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

phototherapy

phototherapy either UVA1 or topical PUVA on acral vitiligo

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with acral vitiligo.
* Patients more than 12 years old.

Exclusion Criteria

* Patients less than 12 years old.
* Patients with any other skin diseases or autoimmune diseases.
* Patients taking medical treatment or phototherapy for vitiligo.
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maha Fathy Elmasry

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maha Elmasry

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maha Fathy Elmasry

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Dermatology 3

Identifier Type: -

Identifier Source: org_study_id